Email This Article

Headlines & Perspectives
Dendreon Shares Soar on Provenge Data
By Adam Feuerstein
10/06/08 - 11:54 AM EDT
Its prostate cancer vaccine appears to cut the risk of death compared with a placebo, but interim results aren't enough to stop the ongoing clinical trial early.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,309.92 1,091.49 2,138.44 32.31
Oil *
77.12
DOWN
154.48
DOWN
19.14
DOWN
37.61
DOWN
0.48
10 Yr
3.23%
SPDR Gold
115.06
-1.48%
-1.72%
-1.73%
-1.46%
Data delayed 20 minutes

Brokerage Partners